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MicroRNAs make big splash in apoptosis
 
undreds of microRNAs are encoded 
in animal genomes, yet the function 
of only two were known until recently. 
That number has now doubled with the 
identification of two miRNAs, 
 
mir14
 
 and 
 
bantam
 
, both of which appear to regulate 
cell death in 
 
Drosophila
 
, according to 
reports from Peizhang Xu, Bruce Hay 
(California Institute of Technology, 
Pasadena, CA), and colleagues and from 
Julius Brennecke, David Hipfner, Alex 
Stark, Rob Russell, and Stephen Cohen 
(EMBL, Heidelberg, Germany).
Cohen’s group went looking for 
genes involved in growth control using
a P-element–based overexpression 
screen. They found 
 
bantam
 
, an miRNA, 
that when overexpressed causes a 
suppression of cell death and an increase 
in cell proliferation.
Using a computer program designed to 
identify miRNA targets, they found that 
bantam controls apoptosis by binding to 
 
hid
 
 mRNA, suppressing its translation 
and blocking its pro-death activity. They 
H
 
Shared amyloid oligomer structure proves toxic
 
t was previously thought that the 
toxicity of A
 
 
 
 and other amyloids 
resulted from large insoluble fibrils, 
but recently researchers have found 
that smaller soluble intermediates 
are cytotoxic. Now, Rakez Kayed, 
Elizabeth Head, Charles Glabe 
(University of California, Irvine, 
CA), and colleagues show that all 
of the soluble amyloid oligomers 
tested share a similar structure, and 
therefore also likely share a common 
mechanism of pathogenesis.
Numerous degenerative diseases 
show evidence of amyloid formation. 
When the Irvine team raised anti-
bodies against soluble A
 
 
 
 oligomers, 
I
 
they obtained a highly specific antibody that binds to antigens 
based on structure, not amino acid sequence. The antibody 
binds to A
 
 
 
 oligomers, but not to A
 
 
 
 monomers or fibrils, 
or to the natively folded amyloid precursor protein. It also 
binds strongly and specifically to oligomers formed by 
 
have not yet found the target 
mRNA involved in the prolif-
eration portion of the bantam 
phenotype, but they have ruled 
out a number of the “usual 
suspects,” says Cohen. Identifi-
cation of miRNA target genes 
has been a stumbling block thus far in 
the miRNA field. The group is currently 
working to further validate their compu-
tational method.
Xu et al., on the other hand, found 
 
mir14
 
 and several other miRNAs in a 
large-scale genetic screen designed to 
identify suppressors of apoptosis. Out of 
7,000 chromosomes screened over four 
years ago, they had ten hits, six of which 
were proteins and relatively easy to identify. 
However, the remaining four—all of 
which now appear to be miRNAs, including 
 
bantam
 
 and 
 
mir14
 
—were initially intrac-
table, says Hay.
He points out that the irony of this story 
is that the power of genetic screens is to let 
the organism tell you what is important 
and to show you novel things. Of course 
the team knew about miRNAs in 
 
C. elegans
 
, 
but four years ago, they were still “stuck 
inside the protein box” and didn’t 
seriously consider the possibility that their 
intractable mutants might be noncoding 
RNAs. That is, not until RNA silencing 
and miRNAs became a more familiar 
concept. “If there is a lesson to be learned,” 
says Hay, “it is to listen harder to what 
your screens are trying to tell you. This 
one did exactly what it was supposed to 
do, we just weren’t listening as closely as 
we should have been.” 
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Elimination of bantam expression (green) by an 
miRNA allows proliferation as illustrated by BrdU 
incorporation (purple).
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numerous other amyloid proteins, 
including 
 
 
 
-synuclein, islet amyloid 
polypeptide, polyglutamine, human 
insulin, lysozyme, and prion peptide 
106–126. Preincubation of the anti-
body with any of these oligomers 
blocks their cytotoxicity.
“One of the real canons of bio-
chemistry is that structure determines 
function. So if they all have the same 
structure, then they must all have 
a similar function, and all be doing 
something similar that is bad,” says 
Glabe. Yet, many of the proposed 
mechanisms make sense for only 
one of the numerous amyloid 
diseases, which rules them out in 
Preincubation of the antibody with oligomers 
(open bars) protected cells, whereas absence of 
antibodies and control antibodies had no effect.
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Glabe’s view. The real twist, he says, is that about half 
of the proteins act extracellularly and half intracellularly, 
leaving pretty much only the plasma membrane as a shared 
target. 
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